Skip to content
(515) 717-7648
WellForm MD
Stethoscope and blank information cards

Mental health education

EXOMIND and rTMS: treatment education and safety

Understand rTMS, device-specific FDA clearance, clinical screening and safety. New EXOMIND inquiries and purchases are paused pending clinic-device and service verification.

Read mental health resourcesCall 988 for crisis support
  • Educational information
  • New EXOMIND acquisition paused

Education and safety

Understand rTMS and discuss options with your established clinician.

Device-specific evidence

Clearance does not identify the clinic’s installed equipment or clinical scope.

Current availability

New EXOMIND inquiries and purchases remain paused.

Stethoscope and blank information cards

The treatment in plain language

What rTMS does

Repetitive transcranial magnetic stimulation (rTMS) uses magnetic pulses to stimulate targeted brain areas. It is generally delivered in an outpatient setting without anesthesia. A qualified clinician must assess whether it fits an individual care plan. Read the NIMH overview.

Current EXOMIND availability

New EXOMIND inquiries, session purchases and package sales are paused while clinic-device correspondence, clinical scope and commercial terms are verified. This page does not establish availability or eligibility. Existing patients should use their established secure care channel for continuity questions.

Clearance belongs to a specific device and indication

FDA record K212723 describes BTL-995 for adult major depressive disorder after an inadequate antidepressant response in the current episode. FDA record K260691 describes BTL-699 with additional device-specific indications, including adjunctive OCD treatment and adjunctive adolescent MDD treatment at ages 15–21. Neither record identifies the equipment installed at WellForm MD. A brand name or predicate-device relationship does not establish the clinic's model, instructions for use or authorized treatment scope.

Screening and treatment planning

Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

Benefits are not guaranteed; risks need review

NIMH describes possible scalp discomfort, headache and lightheadedness, and a low risk of seizure. Risks and contraindications require device-specific clinical review. Treatment response varies; claims about weight loss, cravings, cognitive optimization or guaranteed outcomes are not established here. Review NIMH's safety information.

Illustrative imagery; the clinic’s installed device and treatment scope require verification.

Your treatment plan

Screening and treatment planning

Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

  1. 1

    Current EXOMIND availability

    New EXOMIND inquiries, session purchases and package sales are paused while clinic-device correspondence, clinical scope and commercial terms are verified. This page does not establish availability or eligibility. Existing patients should use their established secure care channel for continuity questions.

  2. 2

    Clearance belongs to a specific device and indication

    FDA record K212723 describes BTL-995 for adult major depressive disorder after an inadequate antidepressant response in the current episode. FDA record K260691 describes BTL-699 with additional device-specific indications, including adjunctive OCD treatment and adjunctive adolescent MDD treatment at ages 15–21. Neither record identifies the equipment installed at WellForm MD. A brand name or predicate-device relationship does not establish the clinic's model, instructions for use or authorized treatment scope.

  3. 3

    Screening and treatment planning

    Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

  4. 4

    Benefits are not guaranteed; risks need review

    NIMH describes possible scalp discomfort, headache and lightheadedness, and a low risk of seizure. Risks and contraindications require device-specific clinical review. Treatment response varies; claims about weight loss, cravings, cognitive optimization or guaranteed outcomes are not established here. Review NIMH's safety information.

Ready when you are

Request your EXOMIND and rTMS: treatment education and safety.

Educational information · New EXOMIND acquisition paused

Read mental health resourcesCall 988 for crisis support

Your EXOMIND session

Screening and ongoing care

Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

  1. 1

    Screening and treatment planning

    Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

  2. 2

    Benefits are not guaranteed; risks need review

    NIMH describes possible scalp discomfort, headache and lightheadedness, and a low risk of seizure. Risks and contraindications require device-specific clinical review. Treatment response varies; claims about weight loss, cravings, cognitive optimization or guaranteed outcomes are not established here. Review NIMH's safety information.

  3. 3

    Continue care and get urgent help when needed

    Continue working with your established mental health professionals. For emotional distress or a suicidal crisis in the United States, call or text 988 or visit the 988 Lifeline. Call 911 for an immediate emergency. This website and its inquiry forms are not emergency services.

Who it may fit

Clearance belongs to a specific device and indication

FDA record K212723 describes BTL-995 for adult major depressive disorder after an inadequate antidepressant response in the current episode. FDA record K260691 describes BTL-699 with additional device-specific indications, including adjunctive OCD treatment and adjunctive adolescent MDD treatment at ages 15–21. Neither record identifies the equipment installed at WellForm MD. A brand name or predicate-device relationship does not establish the clinic's model, instructions for use or authorized treatment scope.

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.
  • Individual clinical review must address benefits, alternatives, risks and contraindications.

Safety screening

Screening and treatment planning

Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.
  • Individual clinical review must address benefits, alternatives, risks and contraindications.
  • This website is not an emergency or crisis service.

Benefits and limitations

Benefits are not guaranteed; risks need review

NIMH describes possible scalp discomfort, headache and lightheadedness, and a low risk of seizure. Risks and contraindications require device-specific clinical review. Treatment response varies; claims about weight loss, cravings, cognitive optimization or guaranteed outcomes are not established here. Review NIMH's safety information.

What treatment may support

  • Keep your established care team involved; do not change prescribed treatment from this website.
  • Individual clinical review must address benefits, alternatives, risks and contraindications.
  • This website is not an emergency or crisis service.

What treatment cannot guarantee

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.
  • Individual clinical review must address benefits, alternatives, risks and contraindications.

Related next steps

Continue care and get urgent help when needed

Continue working with your established mental health professionals. For emotional distress or a suicidal crisis in the United States, call or text 988 or visit the 988 Lifeline. Call 911 for an immediate emergency. This website and its inquiry forms are not emergency services.

Current availability

Current EXOMIND availability

New EXOMIND inquiries, session purchases and package sales are paused while clinic-device correspondence, clinical scope and commercial terms are verified. This page does not establish availability or eligibility. Existing patients should use their established secure care channel for continuity questions.

Education only

New inquiries

Paused

Not accepting new enrollment

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.

Education only

Session purchases

Paused

Not accepting new enrollment

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.

Clearance belongs to a specific device and indication

FDA record K212723 describes BTL-995 for adult major depressive disorder after an inadequate antidepressant response in the current episode. FDA record K260691 describes BTL-699 with additional device-specific indications, including adjunctive OCD treatment and adjunctive adolescent MDD treatment at ages 15–21. Neither record identifies the equipment installed at WellForm MD. A brand name or predicate-device relationship does not establish the clinic's model, instructions for use or authorized treatment scope.

Screening and treatment planning

Discuss diagnosis, previous treatment, medications, implanted devices and metal, seizure history and other relevant medical conditions with a qualified clinician. Screening, protocol, session duration and course length depend on the exact device, its instructions and the individual assessment. Do not stop prescribed medication or change an existing care plan based on this website.

Benefits are not guaranteed; risks need review

NIMH describes possible scalp discomfort, headache and lightheadedness, and a low risk of seizure. Risks and contraindications require device-specific clinical review. Treatment response varies; claims about weight loss, cravings, cognitive optimization or guaranteed outcomes are not established here. Review NIMH's safety information.

New EXOMIND inquiries, session purchases and package sales are paused while clinic-device correspondence, clinical scope and commercial terms are verified. This page does not establish availability or eligibility. Existing patients should use their established secure care channel for continuity questions.

Educational information

Keep your established care team involved

Educational information · New EXOMIND acquisition paused

Read mental health resourcesCall 988 for crisis support

Evidence and responsible care

Clearance belongs to a specific device and indication

FDA record K212723 describes BTL-995 for adult major depressive disorder after an inadequate antidepressant response in the current episode. FDA record K260691 describes BTL-699 with additional device-specific indications, including adjunctive OCD treatment and adjunctive adolescent MDD treatment at ages 15–21. Neither record identifies the equipment installed at WellForm MD. A brand name or predicate-device relationship does not establish the clinic's model, instructions for use or authorized treatment scope.

  • New EXOMIND inquiries and purchases remain paused.
  • The exact installed device, indications and instructions require verification.
  • Keep your established care team involved; do not change prescribed treatment from this website.
  • Individual clinical review must address benefits, alternatives, risks and contraindications.
  • This website is not an emergency or crisis service.

Official resources

FAQ

Questions before you book

Clear answers to the questions most likely to affect your decision.

Resources and continuity

Keep your existing care team involved

Use your established secure care channel for existing treatment questions. For immediate crisis support, call or text 988. New EXOMIND acquisition remains paused.

Read mental health resourcesCall 988 for crisis support
Illustrative portrait of a woman using a telephone

Free consultation. Some appointments require a booking fee to reserve your time; any fee and its terms are confirmed before you book.